AIMEI HEALTH TECHNOLOGY CO., LTD UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks • New York
Aimei Health Technology Co., Ltd, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Spartan Capital Securities, LLC (the “Representative”), as representative of the several underwriters named on Schedule A hereto (the “Underwriters” or, each underwriter individually, an “Underwriter”), as follows (this “Agreement”):
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of December 1, 2023, by and among Aimei Health Technology Co., Ltd., a Cayman Islands exempted company (the “Company”), and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”).
RIGHTS AGREEMENTRights Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks • New York
This Rights Agreement (this “Agreement”) is made as of December 1, 2023 between Aimei Health Technology Co., Ltd, a Cayman Islands exempted company with limited liability, with office at 10 East 53rd Street, Suite 3001, New York, NY 10022 (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited liability trust company, with offices at 1 State Street, 30th Floor, New York, NY 10004 (the “Right Agent”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks • New York
This Agreement, made and entered into effective as of December 1, 2023 (“Agreement”), by and between Aimei Health Technology Co., Ltd., a Cayman Islands exempted company (“Company”), and the undersigned indemnitee (“Indemnitee”).
UNIT SUBSCRIPTION AGREEMENTUnit Subscription Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks • New York
This UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of this December 1, 2023, by and between Aimei Health Technology Co., Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at 10 East 53rd Street, Suite 3001, New York, NY 10022, and Aimei investment Ltd, a Cayman Islands exempted company (the “Purchaser”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks
This Agreement is made effective as of December 1, 2023 by and between Aimei Health Technology Co., Ltd. (the “Company”) and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the “Trustee”).
Aimei Health Technology Co., LtdLetter Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks
This letter agreement by and between Aimei Health Technology Co., Ltd (the “Company”) and Aimei Investment Ltd (“Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on The Nasdaq Global Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (collectively the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):
Aimei Health Technology Co., Ltd December 1, 2023Letter Agreement • December 7th, 2023 • Aimei Health Technology Co., Ltd. • Blank checks
This letter (“Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Aimei Health Technology Co., Ltd, a Cayman Islands exempted company (the “Company”), and Spartan Capital Securities, LLC as representative (the “Representative”) of the several underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each Unit comprised of one ordinary share of the Company, par value $0.0001 (the “Ordinary Shares”) and one right to receive one-fifth (1/5 of one Ordinary Share (each, a “Right”). Certain capitalized terms used herein are defined in paragraph 12 hereof.
